Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) (Unaudited) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended
	Mar. 31, 2025	Mar. 31, 2024
Revenues:
Net product sales	$ 38,903	$ 34,670
Cost of product sales	8,457	8,444
Gross profit	30,446	26,226
Operating expenses:
Research and development	2,279	4,608
General and administrative	12,702	14,974
Sales and marketing	12,311	11,442
Total operating expenses	27,292	31,024
Income (loss) from operations	3,154	(4,798)
Other (expense) income, net	(519)	1,638
Net income (loss)	2,635	(3,160)
Other comprehensive loss:
Unrealized losses on short-term investments	(12)	(19)
Comprehensive income (loss)	$ 2,623	$ (3,179)
Basic net income (loss) per share	$ 0.02	$ (0.02)
Diluted net income (loss) per share	$ 0.01	$ (0.02)
Weighted average common shares outstanding, basic	153,490	151,199
Weighted average common shares outstanding, diluted	196,921	151,199